Page last updated: 2024-09-05

scutellarin and Cardiac Failure

scutellarin has been researched along with Cardiac Failure in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Feng, S; Liu, X; Lu, Y; Pan, Z; Sun, X; Wang, B; Wang, J; Yang, B; Zhang, X; Zhao, W	1

Other Studies

1 other study(ies) available for scutellarin and Cardiac Failure

Article	Year
Scutellarin alleviates interstitial fibrosis and cardiac dysfunction of infarct rats by inhibiting TGFβ1 expression and activation of p38-MAPK and ERK1/2. British journal of pharmacology, 2011, Volume: 162, Issue:3 Topics: Animals; Apigenin; Collagen; Cytokines; Drugs, Chinese Herbal; Echocardiography; Erigeron; Fibrosis; Glucuronates; Heart Failure; Hemodynamics; Male; Mitogen-Activated Protein Kinase 1; Myocardial Infarction; p38 Mitogen-Activated Protein Kinases; Phytotherapy; Rats; Rats, Wistar; Transforming Growth Factor beta1; Ventricular Dysfunction, Left; Ventricular Remodeling	2011

Article

Year

Scutellarin alleviates interstitial fibrosis and cardiac dysfunction of infarct rats by inhibiting TGFβ1 expression and activation of p38-MAPK and ERK1/2.

British journal of pharmacology, 2011, Volume: 162, Issue:3

Topics: Animals; Apigenin; Collagen; Cytokines; Drugs, Chinese Herbal; Echocardiography; Erigeron; Fibrosis; Glucuronates; Heart Failure; Hemodynamics; Male; Mitogen-Activated Protein Kinase 1; Myocardial Infarction; p38 Mitogen-Activated Protein Kinases; Phytotherapy; Rats; Rats, Wistar; Transforming Growth Factor beta1; Ventricular Dysfunction, Left; Ventricular Remodeling

2011